Sharing innovation to inspire action

Sanofi collaborates to develop novel mRNA vaccine candidate against COVID-19

post-image
Pharmaceutical company Sanofi will collaborate with clinical-stage messenger RNA therapeutics company to develop a novel mRNA vaccine for COVID-19. This will be Sanofi's second collaboration in the effort to develop a novel COVID-19 vaccine candidate. Their vaccine expertise from external research networks will assist in advancing vaccine candidates for potential further development. Translate Bio is producing multiple mRNA constructs and will use their mRNA platform to discover, design and manufacture a number of SARS-CoV-2 vaccine candidates. | https://bit.ly/2X5fsA3
What do you think?

You must be logged in to post a comment.
Comments
Generic placeholder image

By Mel Raassina

2 April 2020

 
5 Like


Related Posts

Healthcare

post-image

Grapes - an edible sunscreen
24 February 2021 by Jenny Morawsk... 0 Comments
 
4 Like

Healthcare

post-image

Copper is the New Silver
22 February 2021 by Jeremy Ungar 0 Comments
 
2 Like

Healthcare

post-image

A weight loss drug repurposed to save lives
16 February 2021 by Lynn Wood 1 Comments
 
2 Like